LRHC Form 4: Director Ned Siegel Granted 600 Restricted Shares
Ned L. Siegel, a director of La Rosa Holdings Corp. (LRHC), was granted 600 restricted shares of the company’s common stock on 08/11/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ned L. Siegel, a director of La Rosa Holdings Corp. (LRHC), was granted 600 restricted shares of the company’s common stock on 08/11/2025. The grant was recorded at a price of $0 and the shares vest on the date of grant under the Second Amended and Restated La Rosa Holdings Corp. 2022 Equity Incentive Plan. Following the transaction, Mr. Siegel beneficially owns 600 shares directly. The Form 4 was signed by Mr. Siegel on 08/18/2025.
Positive
- Director equity alignment: 600 restricted shares granted to director Ned L. Siegel, aligning management and shareholder interests under the company equity plan
- Clear disclosure: Transaction date, number of shares, vesting and plan reference are explicitly reported on Form 4
Negative
- None.
Insights
TL;DR: Director received a small, immediate-vesting equity grant under the company’s incentive plan, aligning interests with shareholders.
The filing documents a 600-share grant of restricted common stock to director Ned L. Siegel that vests on the grant date and carries a reported price of $0. This appears to be a routine director compensation event under the 2022 Equity Incentive Plan rather than a performance-contingent award. The immediate vesting and zero price indicate these are compensation shares rather than a purchased position. For governance review, the materiality is low given the small share count, but the award does formalize equity alignment between the director and shareholders.
TL;DR: Small non-cash grant recorded; negligible impact on capitalization or investor valuation.
The Form 4 reports a single non-derivative acquisition of 600 restricted common shares by a director on 08/11/2025 with a $0 price and immediate vesting. The disclosure is clear and limited in scope, showing the director’s beneficial ownership increasing by 600 shares. From a securities perspective, the transaction is routine and immaterial to outstanding share count and market capitalization absent additional context on total shares outstanding.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 600 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents shares of restricted common stock, vesting on the date of the grant, granted pursuant to the Second Amended and Restated La Rosa Holdings Corp. 2022 Equity Incentive Plan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Ned L. Siegel report on the LRHC Form 4?
When was the Form 4 signed and filed by the reporting person?
AI-generated analysis. How Rhea-AI works. Not financial advice.